ABSTRACT
We have reported a case of mastoiditis which progressed to meningitis in a 16-year old male patient. CSF (cerebrospinal fluid) anaerobic culture revealed four species of isolated anaerobic bacteria. This is the first case in the literature in which a patient survived childhood polymicrobial anaerobic meningitis diagnosed by MALDI-TOF MS (Matrix Assisted Laser Desorption Ionization - Time of Flight Mass Spectrometry).
Subject(s)
Bacteria, Anaerobic/classification , Bacteria, Anaerobic/isolation & purification , Coinfection/diagnosis , Coinfection/pathology , Mastoiditis/complications , Meningitis, Bacterial/diagnosis , Meningitis, Bacterial/pathology , Adolescent , Bacteriological Techniques , Cerebrospinal Fluid/microbiology , Coinfection/microbiology , Humans , Male , Meningitis, Bacterial/microbiology , Spectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationABSTRACT
Evidence from the literature has shown that Saccharomyces boulardii provides a clinically significant benefit in the treatment of acute infectious diarrhoea in children. In this multicentre, randomised, prospective, controlled, single blind clinical trial performed in children with acute watery diarrhoea, we aimed to evaluate the impact of S. boulardii CNCM I-745 in hospitalised children, in children requiring emergency care unit (ECU) stay and in outpatient settings. The primary endpoint was the duration of diarrhoea (in hours). Secondary outcome measures were duration of hospitalisation and diarrhoea at the 3(rd) day of intervention. In the whole study group (363 children), the duration of diarrhoea was approximately 24 h shorter in the S. boulardii group (75.4±33.1 vs 99.8±32.5 h, P<0.001). The effect of S. boulardii (diarrhoea-free children) was observed starting at 48 h. After 72 h, only 27.3% of the children receiving probiotic still had watery diarrhoea, in contrast to 48.5% in the control group (P<0.001). The duration of diarrhoea was significantly reduced in the probiotic group in hospital, ECU and outpatient settings (P<0.001, P<0.01 and P<0.001, respectively). The percentage of diarrhoea-free children was significantly larger after 48 and 72 h in all settings. The mean length of hospital stay was shorter with more than 36 h difference in the S. boulardii group (4.60±1.72 vs 6.12±1.71 days, P<0.001). The mean length of ECU stay was shorter with more than 19 h difference in the probiotic group (1.20±0.4 vs 2.0±0.3 days, P<0.001). No adverse effects related to the probiotic were noted. Because treatment can shorten the duration of diarrhoea and reduce the length of ECU and hospital stay, there is likely a social and economic benefit of S. boulardii CNCM I-745 in adjunction to oral rehydration solution in acute infectious gastroenteritis in children.
Subject(s)
Diarrhea/pathology , Diarrhea/therapy , Emergency Medical Services , Length of Stay , Probiotics/administration & dosage , Saccharomyces/physiology , Child, Preschool , Female , Humans , Infant , Male , Prospective Studies , Time FactorsABSTRACT
Management of multidrug-resistant Acinetobacter baumannii (MDRAB) meningitis/ventriculitis is a difficult therapeutic problem owing to the limited penetration of antibiotics into cerebrospinal fluid (CSF). A 2-month-old girl with ventriculitis caused by MDRAB is reported. Despite therapy with intravenous (IV) colistin ventricular fluid, cultures remained positive for MDRAB. Institution of combination therapy with IV and intraventricular colistin resulted in a successful clinical and microbiological outcome. Intraventricular/intrathecal and IV colistin might be the best therapeutic option in the treatment of central nervous system infection caused by MDRAB. Further studies are required to evaluate pharmacokinetic and pharmacodynamic parameters of combined IV and intraventricular/intrathecal colistin administration, especially in children.
Subject(s)
Acinetobacter Infections/drug therapy , Acinetobacter baumannii , Anti-Bacterial Agents/administration & dosage , Colistin/administration & dosage , Encephalitis/drug therapy , Meningitis, Bacterial/drug therapy , Acinetobacter Infections/microbiology , Acinetobacter baumannii/drug effects , Cerebral Ventricles , Drug Resistance, Multiple, Bacterial , Encephalitis/microbiology , Female , Humans , Infant , Injections, Intraventricular , Treatment OutcomeABSTRACT
Caffeine, which has a wide range between therapeutic and toxic levels, is a widely used medication for prevention and treatment of apnoea of prematurity. Despite its safety, caffeine overdose and intoxication has been previously reported in the literature. We present a 30-day-old 28-week preterm newborn who was exposed to 300 mg.kg-1 caffeine base by mouth accidentally. The patient exhibited agitations, irritability, tachycardia, tachypnoea, diuresis, electrolyte abnormalities, hyperglycaemia and metabolic acidosis, for which he received supportive treatment. No seizure activity was observed. The effects of intoxication lasted for 96 h and then completely resolved.
